Partnerships - iCAALL

aaaai square rgb   ACAAI LogoColorVert   EAACI LOGO CMYK 300 dpi for website   wao blk log federation

Hundreds of millions of people in the world suffer from allergies, and it is estimated that 300 million have asthma. Inadequate or improper diagnosis and treatment of these chronic diseases and of immunodeficiency disorders results in lost productivity and substantial medical and socioeconomic burdens throughout the world.

Recognizing a lack of consensus-driven information and general recommendations, four of the most influential allergy/immunology professional organizations have joined forces to launch the International Collaboration in Asthma, Allergy and Immunology (iCAALL).


iCAALL is designed to collect and disseminate consensus-driven information about allergies, asthma and immunological diseases. Communicating this knowledge can positively impact diagnosis and treatment, as well as cost containment and policy decisions.

A major focus of this initiative is the production of a series of International Consensus (ICON) reports. These documents offer general recommendations based on global challenges in caring for patients with allergic and immunologic diseases.

To read ICON reports Click here.

Last updated 11 October 2018
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel